Literature DB >> 24251951

Insulin resistance and impaired mitochondrial function in obese adolescent girls.

Meghan J Slattery1, Miriam A Bredella, Hena Thakur, Martin Torriani, Madhusmita Misra.   

Abstract

BACKGROUND: Mitochondrial dysfunction plays a role in the development of muscle insulin resistance (IR) and the accumulation of intramyocellular lipid (IMCL) in skeletal muscle that can, in turn, interfere with insulin signaling. The purpose of this study was to assess mitochondrial function (MF) and IMCL in obese adolescent girls with and without IR to determine whether: (1) Girls with IR have impaired MF, and (2) impaired MF in girls with IR is related to higher IMCL.
METHODS: We examined 22 obese girls aged 13-21 years old for IR [defined as a homeostasis model assessment of insulin resistance (HOMA-IR) value >4. Phosphorus magnetic resonance spectroscopy (31P-MRS) and proton magnetic resonance spectroscopy (1H-MRS), respectively, were used to determine MF and IMCL of the soleus muscle along with magnetic resonance imaging (MRI) measures of visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT) in girls with HOMA-IR >4 (insulin-resistant group) versus HOMA-IR ≤ 4 (insulin-sensitive group). Serum lipids and waist-to-hip ratio (W/H) were also measured.
RESULTS: Girls with IR (n=8) did not differ from the insulin-sensitive group (n=14) for age, bone age, weight, VAT, SAT, TAT, or IMCL. However, the insulin-resistant group had higher W/H. Additionally the insulin-resistance group had a lower log rate of postexercise phosphocreatine (PCr) recovery (ViPCr) and a higher log PCr recovery constant (tau), indicative of impaired MF.
CONCLUSIONS: Obese girls with increased IR have impaired mitochondrial function. This association is not mediated by alterations in IMCL or adipose tissue. Further studies are necessary to determine whether there is a causal relation between impaired mitochondrial function and IR in obesity and mediators of such a relationship.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24251951      PMCID: PMC3942687          DOI: 10.1089/met.2013.0100

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  35 in total

1.  Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women.

Authors:  M Brochu; R D Starling; A Tchernof; D E Matthews; E Garcia-Rubi; E T Poehlman
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

2.  Comparison of 3.0 T proton magnetic resonance spectroscopy short and long echo-time measures of intramyocellular lipids in obese and normal-weight women.

Authors:  Miriam A Bredella; Reza Hosseini Ghomi; Bijoy J Thomas; Karen K Miller; Martin Torriani
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

Review 3.  Intramyocellular lipid content in human skeletal muscle.

Authors:  Vera B Schrauwen-Hinderling; Matthijs K C Hesselink; Patrick Schrauwen; Marianne Eline Kooi
Journal:  Obesity (Silver Spring)       Date:  2006-03       Impact factor: 5.002

4.  Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate.

Authors:  C Schmitz-Peiffer; D L Craig; T J Biden
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

5.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

6.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2012-01-17       Impact factor: 56.272

7.  Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.

Authors:  V B Schrauwen-Hinderling; M E Kooi; M K C Hesselink; J A L Jeneson; W H Backes; C J A van Echteld; J M A van Engelshoven; M Mensink; P Schrauwen
Journal:  Diabetologia       Date:  2006-11-09       Impact factor: 10.122

8.  Insulin resistance during puberty: results from clamp studies in 357 children.

Authors:  A Moran; D R Jacobs; J Steinberger; C P Hong; R Prineas; R Luepker; A R Sinaiko
Journal:  Diabetes       Date:  1999-10       Impact factor: 9.461

9.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

Authors:  R A DeFronzo; R Gunnarsson; O Björkman; M Olsson; J Wahren
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

10.  Obesity in the transition to adulthood: predictions across race/ethnicity, immigrant generation, and sex.

Authors:  Kathleen Mullan Harris; Krista M Perreira; Dohoon Lee
Journal:  Arch Pediatr Adolesc Med       Date:  2009-11
View more
  13 in total

1.  Metabolomics allows the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children.

Authors:  G Á Martos-Moreno; A Mastrangelo; V Barrios; A García; J A Chowen; F J Rupérez; C Barbas; J Argente
Journal:  Int J Obes (Lond)       Date:  2017-06-07       Impact factor: 5.095

Review 2.  The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated Overview.

Authors:  Dimitrios Tsilingiris; Evangelia Tzeravini; Chrysi Koliaki; Maria Dalamaga; Alexander Kokkinos
Journal:  Curr Obes Rep       Date:  2021-04-10

Review 3.  Mitochondria: diversity in the regulation of the NLRP3 inflammasome.

Authors:  Prajwal Gurung; John R Lukens; Thirumala-Devi Kanneganti
Journal:  Trends Mol Med       Date:  2014-11-27       Impact factor: 11.951

4.  Obesity-related differences in neuromuscular fatigue in adolescent girls.

Authors:  Sebastian Garcia-Vicencio; Vincent Martin; Virginie Kluka; Charlotte Cardenoux; Anne-Gaëlle Jegu; Anne-Véronique Fourot; Emmanuel Coudeyre; Sébastien Ratel
Journal:  Eur J Appl Physiol       Date:  2015-07-24       Impact factor: 3.078

5.  Insulin Resistance in Youth Without Diabetes Is Not Related to Muscle Mitochondrial Dysfunction.

Authors:  Melanie Cree-Green; Ninghe Cai; Laura Pyle; Brandy Ringham; Mark S Brown; Bradley R Newcomer; Kristen J Nadeau; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

6.  Crosstalk between circulating peroxisome proliferator-activated receptor gamma, adipokines and metabolic syndrome in obese subjects.

Authors:  Khadijeh Mirzaei; Arash Hossein-Nezhad; Seyed Ali Keshavarz; Fariba Koohdani; Ali Akbar Saboor-Yaraghi; Saeed Hosseini; Mohammad Reza Eshraghian; Mahmoud Djalali
Journal:  Diabetol Metab Syndr       Date:  2013-12-12       Impact factor: 3.320

7.  Effects of recombinant human growth hormone (rhGH) administration on body composition and cardiovascular risk factors in obese adolescent girls.

Authors:  Meghan Slattery; Miriam A Bredella; Takara Stanley; Martin Torriani; Madhusmita Misra
Journal:  Int J Pediatr Endocrinol       Date:  2014-11-15

Review 8.  Muscle Strength and Fitness in Pediatric Obesity: a Systematic Review from the European Childhood Obesity Group.

Authors:  David Thivel; Susanne Ring-Dimitriou; Daniel Weghuber; Marie-Laure Frelut; Grace O'Malley
Journal:  Obes Facts       Date:  2016-02-23       Impact factor: 3.942

9.  High-fat diet affects skeletal muscle mitochondria comparable to pressure overload-induced heart failure.

Authors:  Estelle Heyne; Andrea Schrepper; Torsten Doenst; Christina Schenkl; Katrin Kreuzer; Michael Schwarzer
Journal:  J Cell Mol Med       Date:  2020-05-04       Impact factor: 5.310

10.  Early oxidative shifts in mouse skeletal muscle morphology with high-fat diet consumption do not lead to functional improvements.

Authors:  Melissa M Thomas; Karin E Trajcevski; Samantha K Coleman; Maggie Jiang; Joseph Di Michele; Hayley M O'Neill; James S Lally; Gregory R Steinberg; Thomas J Hawke
Journal:  Physiol Rep       Date:  2014-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.